CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy. - Stringer-Reasor E; Li Y; Zhang J; Rocque G; Jones K; O'Sullivan C; Giridhar K; Dees EC; Nanda R; Hunter N; Clark A; Wolff A; et al. (Journal of the National Comprehensive Cancer Network : JNCCN, 2026)